Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Circulating Tumor Cell (CTC) Diagnostics Market Research Report 2019-2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Circulating Tumor Cell (CTC) Diagnostics Industry
  • 1.7 COVID-19 Impact: Circulating Tumor Cell (CTC) Diagnostics Market Trends

    • 2 Global Circulating Tumor Cell (CTC) Diagnostics Quarterly Market Size Analysis

    • 2.1 Circulating Tumor Cell (CTC) Diagnostics Business Impact Assessment - COVID-19
      • 2.1.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Circulating Tumor Cell (CTC) Diagnostics Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Circulating Tumor Cell (CTC) Diagnostics Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Circulating Tumor Cell (CTC) Diagnostics Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Circulating Tumor Cell (CTC) Diagnostics Market
    • 3.4 Key Players Circulating Tumor Cell (CTC) Diagnostics Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Circulating Tumor Cell (CTC) Diagnostics Segments, By Type

    • 4.1 Introduction
      • 1.4.1 CTC Enrichment
      • 1.4.2 CTC Detection
    • 4.2 By Type, Global Circulating Tumor Cell (CTC) Diagnostics Market Size, 2019-2021

    5 Impact of Covid-19 on Circulating Tumor Cell (CTC) Diagnostics Segments, By Application

    • 5.1 Overview
      • 5.5.1 Hospitals and clinics
      • 5.5.2 Pharmaceuticals and biotechnology companies
      • 5.5.3 Academic research institutes
      • 5.5.4 CROs
    • 5.2 By Application, Global Circulating Tumor Cell (CTC) Diagnostics Market Size, 2019-2021
      • 5.2.1 By Application, Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 ApoCell, Inc.(US)
      • 7.1.1 ApoCell, Inc.(US) Business Overview
      • 7.1.2 ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Quarterly Revenue, 2020
      • 7.1.3 ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Introduction
      • 7.1.4 ApoCell, Inc.(US) Response to COVID-19 and Related Developments
    • 7.2 Biocep Ltd. (Israel)
      • 7.2.1 Biocep Ltd. (Israel) Business Overview
      • 7.2.2 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Quarterly Revenue, 2020
      • 7.2.3 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Product Introduction
      • 7.2.4 Biocep Ltd. (Israel) Response to COVID-19 and Related Developments
    • 7.3 Biocept, Inc.(US)
      • 7.3.1 Biocept, Inc.(US) Business Overview
      • 7.3.2 Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Quarterly Revenue, 2020
      • 7.3.3 Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Introduction
      • 7.3.4 Biocept, Inc.(US) Response to COVID-19 and Related Developments
    • 7.4 Biofluidica MicrotechnologiesLLc(US)
      • 7.4.1 Biofluidica MicrotechnologiesLLc(US) Business Overview
      • 7.4.2 Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Quarterly Revenue, 2020
      • 7.4.3 Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Product Introduction
      • 7.4.4 Biofluidica MicrotechnologiesLLc(US) Response to COVID-19 and Related Developments
    • 7.5 Celltraffix Inc.(US)
      • 7.5.1 Celltraffix Inc.(US) Business Overview
      • 7.5.2 Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Quarterly Revenue, 2020
      • 7.5.3 Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Introduction
      • 7.5.4 Celltraffix Inc.(US) Response to COVID-19 and Related Developments
    • 7.6 ClearbridgeBiomedics(Singapore)
      • 7.6.1 ClearbridgeBiomedics(Singapore) Business Overview
      • 7.6.2 ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Quarterly Revenue, 2020
      • 7.6.3 ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Product Introduction
      • 7.6.4 ClearbridgeBiomedics(Singapore) Response to COVID-19 and Related Developments
    • 7.7 Creatv Microtech, Inc.(US)
      • 7.7.1 Creatv Microtech, Inc.(US) Business Overview
      • 7.7.2 Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Quarterly Revenue, 2020
      • 7.7.3 Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Introduction
      • 7.7.4 Creatv Microtech, Inc.(US) Response to COVID-19 and Related Developments
    • 7.8 CynvenioBiosystems, Inc.(US)
      • 7.8.1 CynvenioBiosystems, Inc.(US) Business Overview
      • 7.8.2 CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Quarterly Revenue, 2020
      • 7.8.3 CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Introduction
      • 7.8.4 CynvenioBiosystems, Inc.(US) Response to COVID-19 and Related Developments
    • 7.9 EpicBiosciencesInc.(US)
      • 7.9.1 EpicBiosciencesInc.(US) Business Overview
      • 7.9.2 EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Quarterly Revenue, 2020
      • 7.9.3 EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Introduction
      • 7.9.4 EpicBiosciencesInc.(US) Response to COVID-19 and Related Developments
    • 7.10 FluxionBiosciences, Inc.(US)
      • 7.10.1 FluxionBiosciences, Inc.(US) Business Overview
      • 7.10.2 FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Quarterly Revenue, 2020
      • 7.10.3 FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Introduction
      • 7.10.4 FluxionBiosciences, Inc.(US) Response to COVID-19 and Related Developments
    • 7.11 Ikonisys, Inc.(US)
      • 7.11.1 Ikonisys, Inc.(US) Business Overview
      • 7.11.2 Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Quarterly Revenue, 2020
      • 7.11.3 Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Introduction
      • 7.11.4 Ikonisys, Inc.(US) Response to COVID-19 and Related Developments
    • 7.12 IVDiagnostics, Inc.(US)
      • 7.12.1 IVDiagnostics, Inc.(US) Business Overview
      • 7.12.2 IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Quarterly Revenue, 2020
      • 7.12.3 IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Introduction
      • 7.12.4 IVDiagnostics, Inc.(US) Response to COVID-19 and Related Developments
    • 7.13 JanssenDiagnosticsLLc(US)
      • 7.13.1 JanssenDiagnosticsLLc(US) Business Overview
      • 7.13.2 JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Quarterly Revenue, 2020
      • 7.13.3 JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Product Introduction
      • 7.13.4 JanssenDiagnosticsLLc(US) Response to COVID-19 and Related Developments
    • 7.14 QIAGEnHannoverGmbH (Germany)
      • 7.14.1 QIAGEnHannoverGmbH (Germany) Business Overview
      • 7.14.2 QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Quarterly Revenue, 2020
      • 7.14.3 QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Product Introduction
      • 7.14.4 QIAGEnHannoverGmbH (Germany) Response to COVID-19 and Related Developments
    • 7.15 RARECELLsSAs(Italy)
      • 7.15.1 RARECELLsSAs(Italy) Business Overview
      • 7.15.2 RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Quarterly Revenue, 2020
      • 7.15.3 RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Product Introduction
      • 7.15.4 RARECELLsSAs(Italy) Response to COVID-19 and Related Developments
    • 7.16 ScreenCell(France)
      • 7.16.1 ScreenCell(France) Business Overview
      • 7.16.2 ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Quarterly Revenue, 2020
      • 7.16.3 ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Product Introduction
      • 7.16.4 ScreenCell(France) Response to COVID-19 and Related Developments
    • 7.17 STEMCELlTechnologies, Inc.(Canada)
      • 7.17.1 STEMCELlTechnologies, Inc.(Canada) Business Overview
      • 7.17.2 STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Quarterly Revenue, 2020
      • 7.17.3 STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Product Introduction
      • 7.17.4 STEMCELlTechnologies, Inc.(Canada) Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of Circulating Tumor Cell (CTC) Diagnostics, including the following market information:
      Global Circulating Tumor Cell (CTC) Diagnostics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include ApoCell, Inc.(US), Biocep Ltd. (Israel), Biocept, Inc.(US), Biofluidica MicrotechnologiesLLc(US), Celltraffix Inc.(US), ClearbridgeBiomedics(Singapore), Creatv Microtech, Inc.(US), CynvenioBiosystems, Inc.(US), EpicBiosciencesInc.(US), FluxionBiosciences, Inc.(US), Ikonisys, Inc.(US), IVDiagnostics, Inc.(US), JanssenDiagnosticsLLc(US), QIAGEnHannoverGmbH (Germany), RARECELLsSAs(Italy), ScreenCell(France), STEMCELlTechnologies, Inc.(Canada), etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      CTC Enrichment
      CTC Detection

      Based on the Application:
      Hospitals and clinics
      Pharmaceuticals and biotechnology companies
      Academic research institutes
      CROs

      Buy now